drugcoverage - Erbitux - ImClone Systems Incorporated under licence by Bristol-Myers Squibb Canada

Medication Brand Name:

Erbitux

Active Ingredient:

cetuximab

DIN(s) in Canada:

02271249

francais

Manufacturer/Distributor:

ImClone Systems Incorporated under licence by Bristol-Myers Squibb Canada

DrugCoverage Category:

Cancer

See Also:

ERBITUX is currently under reveiw for funding by the provincial /territorial funding agencies. ERBITUX is an eligible benefit through some private insurance plans. Helping make ERBITUX treatment accessible to patients, the Access to Hope Program 1-877-967-6626, will assist patients throughout the ERBITUX reimbursement process. For more detailed information (including the Access to Hope Program Enrolment Form) click HERE.

Coverage/Reimbursement by Private Insurance Plans in Canada

ERBITUX is an eligible benefit through some private insurance plans. Some plans may require prior authorization before granting coverage. Helping make ERBITUX treatment accessible to patients, the Access to Hope Program 1-877-967-6626, will assist patients throughout the ERBITUX reimbursement process. For more detailed information (including the Access to Hope Program Enrolment Form) click HERE.

Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province	Coverage	Program / Eligibility Criteria
AB		Erbitux is covered according to eligibility criteria by the Alberta Cancer Board
BC		Erbitux is covered according to eligibility criteria for some indications through the BC Cancer Agency
MB		Erbitux is under review by the provincial funding agency.
NB		Erbitux is under review by the provincial funding agency.
NL		Erbitux is under review by the provincial funding agency.
NT		Erbitux is under review by the territorial funding agency.
NS		Erbitux is covered according to eligibility criteria for some indications through Cancer Care Nova Scotia
NU		Erbitux is under review by the territorial funding agency.
ON		Erbitux is covered according to eligibility criteria for some indications through Cancer Care Ontario
PE		Erbitux is under review by the provincial funding agency.
QC		Erbitux is covered according to eligibility criteria for some indications through Quebec hospitals.
SK		Erbitux is under review by the provincial funding agency.
YT		Erbitux is under review by the territorial funding agency.

Coverage/Reimbursement by Canadian Federal Plans
Plan	Coverage	Program / Eligibility Criteria
Public Services Health Care Plan		Erbitux may be covered by the PSHCP
Non-Insured Health Benefits Program		Erbitux is currently under review by the NIHB
Veterans Affairs Canada		Erbitux is currently under review by Veterans Affairs Canada
Canadian Forces Health Services		Erbitux is currently under review by the Canadian Forces Health Services